VALID TRIAL
Both CHIA and your personal trial have the following criteria:
╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                                  │ CHIA Criteria                                      │   Score │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╪═════════╡
│ Post menopausal women with a history of estrogen   │ Post menopausal women with a history of estrogen   │     100 │
│ positive breast cancer who are receiving aromatase │ positive breast cancer who are receiving aromatase │         │
│ inhibitors for at least one month                  │ inhibitors for at least one month                  │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Patients must complain of mild to moderate         │ Patients must complain of mild to moderate         │     100 │
│ arthralgia                                         │ arthralgia                                         │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Ability to understand and sign informed consent    │ Ability to understand and sign informed consent    │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Patients meet criteria for low to moderate risk    │ Patients meet criteria for low to moderate risk    │     100 │
│ for moderate exercise based oon the ACSM           │ for moderate exercise based oon the ACSM           │         │
│ guidelines                                         │ guidelines                                         │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Inability to comply with study requirements        │ Inability to comply with study requirements        │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Metastatic breast cancer                           │ Metastatic breast cancer                           │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Patients with orthopedic or neuromuscular          │ Patients with orthopedic or neuromuscular          │     100 │
│ disorders that preclude participation in exercise  │ disorders that preclude participation in exercise  │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Rheumatoid arthritis                               │ Rheumatoid arthritis                               │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ History of MI, angina or congestive heart failure  │ History of MI, angina or congestive heart failure  │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Pregnant or lactating females                      │ Pregnant or lactating females                      │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Patients that are high risk for moderate exercise  │ Patients that are high risk for moderate exercise  │     100 │
│ based on ACSM risk classification                  │ based on ACSM risk classification                  │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Patients who exceed minimal physical activity      │ Patients who exceed minimal physical activity      │     100 │
│ recommendations from the US Surgeon General's      │ recommendations from the US Surgeon General's      │         │
│ Report: Accumulation of 30 minutes or more of      │ Report: Accumulation of 30 minutes or more of      │         │
│ moderate physical activity on most days of the     │ moderate physical activity on most days of the     │         │
│ week                                               │ week                                               │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Morbidly obese with BMI ≥ 40                       │ Morbidly obese with BMI ≥ 40                       │     100 │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╧═════════╛

Only your personal trial has the following criteria:
╒═══════════════════════════════════╤══════════════════════════╤═════════╕
│ Personal Criteria                 │ CHIA Criteria            │   Score │
╞═══════════════════════════════════╪══════════════════════════╪═════════╡
│ Must be FEMALE                    │ Metastatic breast cancer │      37 │
├───────────────────────────────────┼──────────────────────────┼─────────┤
│ Must have minimum age of 18 Years │ Rheumatoid arthritis     │      38 │
╘═══════════════════════════════════╧══════════════════════════╧═════════╛

CHIA has no unique criteria

Levenshtein Ratio of Entire trial at once: 97
Average Levenshtein Ratio of individual lines: 91.66666666666667
OverAll Ratio: 94.33333333333334
